Company intelligence / Profile preview

Triderm

Ownership: Private
Development stage: Other

Overview

Triderm is a pharmaceutical company primarily focused on the development and commercialization of dermatological treatments. The company is best known for its topical corticosteroid products, particularly Triderm cream, which is used to treat various inflammatory skin conditions such as dermatitis, eczema, and psoriasis. Triderm's business model centers on providing accessible, high-quality generic and branded dermatological solutions to patients. The company maintains a strong presence in the topical medication market, leveraging established manufacturing processes for creams and ointments.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Triderm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triderm.

Explore the full profile